Trial of Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccine

NCT02722512 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

10

Enrollment

OTHER

Sponsor class

Stopped Lack of substantial evidence for immune responses in response to vaccination.

Conditions

Glioblastoma Multiforme
Astrocytoma, Grade III
Anaplastic Ependymoma
Clear Cell Ependymoma
Ependymoma

Interventions

BIOLOGICAL: Heat Shock Protein Peptide Complex-96 (HSPPC-96)
PROCEDURE: Tumor Resection
RADIATION: Radiation

Sponsor

Ann & Robert H Lurie Children's Hospital of Chicago

Collaborators

[object Object]